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Appendix S1: Tests for additional hypothesis Appendix S2: Correlation of ALS lifespan with ANG physicochemical properties Appendix S3: Adjustment of false discovery rate using the Benjamini-Hochberg method Figure S1 Table S1 Appendix S1. ANG-aggregation propensity did not significantly correlate with either onset (p value of 0.395, CI -0.38-0.14) ( Figure S1a Figure S1c ).
Relative ANG-ribonuclease activity was correlated to the onset of PD (n = 17). No significant correlation was observed between the onset of PD and %WT ribonuclease activity of ANG variants (p values range of 0.59-0.60, CI -0.61-0.38) ( Figure S2 ). Correlations with Parkinson's disease duration couldn't be performed as disease duration information was available for only two patients. Similarly, stability of ANG variants cannot be correlated with either PD onset or PD duration as ∆∆G data was only available for two ANG-PD variants.
Appendix S2. To illustrate the lifelong effects of ANG stability and activity, we have correlated these with the total lifespan of ALS patients by adding disease duration to ALS onset time for patients having both the data were reported (patients having only ALS onset data, but no survival data were censored). Consistent with having averaged two competing forces, no significant correlations were observed between total lifespan of ALS patients and either stability (p values range of 0.07-0.08, CI -0.04-0.73) ( Figure S3a Test for Cox proportional hazards assumption (p value of 0.293) indicated there is no violation of the proportionality assumption. Likewise, using the same thresholds to categorize ribonuclease activity and stability, Kaplan-Meier analysis performed above: the median lifespans of patients with low versus high ANG stability and ribonuclease activity were 850 ± 40.7 and 876± 148, and 876 ± 115 versus 834 ± 62.6 months, respectively; and no significant difference was observed between the survival functions of stability categories with respect to total lifespan (p values range of 0.18-0.28) or ribonuclease activity (p values range of 0.62-1) ( Figures S3c and S3d ).
Using the same thresholds to categorize ribonuclease activity and stability, Cox proportional hazards analysis were performed: no significant difference was observed between the hazard ratio of stability categories with respect to total lifespan or ribonuclease activity categories with respect to lifespan and the data was not reported. Tests for proportionality assumption demonstrated non-parallelism between the categories indicating violation of the Cox proportionality hazard model assumption. Note, however, that patients with high ANG stability and activity survive an average of 13 and 9 years longer than the remaining ALS patients.
Appendix S3. Three covariates (ANG stability; ANG aggregation propensity; ANG ribonuclease activity) were correlated, independently, with two datasets (survival and onset). False discovery rate was therefore corrected with respect to correlating three covariates to a particular dataset.
Benjamini-Hochberg method was used to adjust for the false discovery rate. A false discovery rate of 5% was used to adjust for type I error (Table S1 ). A total of 25 analysis were performed on our data. All our p values found significant in our analysis were found to be significant using Benjamini-Hochberg correction except, analysis of mortality risk using Cox proportional hazards model using WT ribonuclease activity as a continuous variable. To increase stringency, we also required significance to be achieved through multiple statistical tests of each hypothesis (e.g. correlation, Kaplan Meier, and Cox; as well as the use of survival hypothesis testing with different weighing functions using Log-rank, Tarone-ware, and Breslow). propensity calculated here is important-its components (i.e. the mathematical terms used to calculate) are the fundamental physicochemical parameters of charge, hydrophobicity, and entropy. Aggregation propensity denotes the likelihood of undergoing a phase transition from an aqueous phase to an aggregated phase (i.e. it pertains to phenomena that occur following the nucleation step that "seeds" the aggregate), and to a first approximation is independent of protein stability or activity. Our study could not address the nucleation step that initiates the aggregation cascade-which could be related to protein stability-because the data were unavailable and cannot be estimated. Meier curves illustrating no significant differences in lifespan between patients with ANG variants with ∆∆G less than or equal to -1 kcal/mol and variants with ∆∆G greater than -1 kcal/mol. d) Kaplan-Meier curves illustrating no significant differences in lifespan between patients with ANG variants with %WT ribonuclease activity less than or equal to 10% and variants with %WT ribonuclease activity greater than 10%. 
